The TNFRSF10B reduced the production of LPS-induced TNF by its ability to neutralize endogenous TRAIL in fresh human PBMC. In this assay, endogenous TRAIL is induced during a 24 hour exposure to LPS (10 ng/ml) but in the presence of TNFRSF10B, TRAIL-induced TNF is suppressed.

Purezza

>95% as determined by SDS-PAGE.

Forma del prodotto

Lyophilized

Concentrazione

Reconstitution dependent.

Formulazione

Lyophilized from Phosphate Buffered Saline, pH 7.4.

Conservazione

Shipped at ambient temperature. Lyophilized: Short term (3 weeks) store at 25°C. Long term store desiccated below -18°C. Reconstituted: Short term (2-7 days) store at 4°C. Long term store below -18°C, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid freeze/thaw cycles.

Sinonimi

Apoptosis inducing protein TRICK2A/2B, Apoptosis inducing receptor TRAIL R2, CD262, CD262 antigen, Cytotoxic TRAIL receptor 2, Death domain containing receptor for TRAIL/Apo 2L, Death receptor 5, Fas like protein, KILLER, KILLER/DR5, OTTHUMP00000123492, OTTHUMP00000123493, p53 regulated DNA damage inducible cell death receptor(killer), TNF related apoptosis inducing ligand receptor 2, TNF-related apoptosis-inducing ligand receptor 2, TNFRSF10B, TR10B_HUMAN, TRAIL R2, TRAIL receptor 2, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, Tumor necrosis factor receptor like protein ZTNFR9, Tumor necrosis factor receptor superfamily member 10B, Tumor necrosis factor receptor superfamily, member 10b, ZTNFR9

Dichiarazione di non responsabilità

Questo prodotto è solo per uso di ricerca. Non è inteso per uso diagnostico o terapeutico.

Prodotti alternativi a Ricombinante Umano DR5 proteinaa (A61503)

A113767

Ricombinante Umano DR5 Proteina (C-terminal His Tag)

Convalidato per SDS-PAGE.

A113767

Ricombinante Umano DR5 Proteina (C-terminal His Tag)

Convalidato per SDS-PAGE.

Consegna

Consegna

Contattaci

Garanzie

Consegna Globale

Supporto dal Vivo

Oltre 100.000 Prodotti

Prezzi Bassi